Terms: = Prostate cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Treatment
10 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia treatment Centres.
Gautier P; Guillet B; Sigaud M; Claeyssens S; Volot FG; Chamouni P; Lienahrt A; Frotscher B; Fournel A; Castet S; Poumayou C; Gay V; Thuret R; Wibaut B; Biron-Andreani C
Haemophilia; 2022 May; 28(3):437-444. PubMed ID: 35201650
[TBL] [Abstract] [Full Text] [Related]
3. Ethacrynic acid inhibits STAT3 activity through the modulation of shp2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells.
Lee YJ; Song H; Yoon YJ; Park SJ; Kim SY; Cho Han D; Kwon BM
Biochem Pharmacol; 2020 May; 175():113920. PubMed ID: 32201212
[TBL] [Abstract] [Full Text] [Related]
4. Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.
Toomey S; Carr A; Mezynski MJ; Elamin Y; Rafee S; Cremona M; Morgan C; Madden S; Abdul-Jalil KI; Gately K; Farrelly A; Kay EW; Kennedy S; O'Byrne K; Grogan L; Breathnach O; Morris PG; Eustace AJ; Fay J; Cummins R; O'Grady A; Kalachand R; O'Donovan N; Kelleher F; O'Reilly A; Doherty M; Crown J; Hennessy BT
J Transl Med; 2020 Feb; 18(1):99. PubMed ID: 32087721
[TBL] [Abstract] [Full Text] [Related]
5. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
Liu Y; Qin Z; Yang K; Liu R; Xu Y
Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
[TBL] [Abstract] [Full Text] [Related]
6. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.
Toso A; Revandkar A; Di Mitri D; Guccini I; Proietti M; Sarti M; Pinton S; Zhang J; Kalathur M; Civenni G; Jarrossay D; Montani E; Marini C; Garcia-Escudero R; Scanziani E; Grassi F; Pandolfi PP; Catapano CV; Alimonti A
Cell Rep; 2014 Oct; 9(1):75-89. PubMed ID: 25263564
[TBL] [Abstract] [Full Text] [Related]
7. In vivo passage of human prostate cancer cells in mice results in stable gene expression changes affecting numerous cancer-associated biological processes.
Sivanathan L; Chow A; Wong A; Hoang VC; Emmenegger U
Prostate; 2014 May; 74(5):537-46. PubMed ID: 24435653
[TBL] [Abstract] [Full Text] [Related]
8. IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity.
Gan Y; Zhang Y; Buckels A; Paterson AJ; Jiang J; Clemens TL; Zhang ZY; Du K; Chang Y; Frank SJ
Mol Endocrinol; 2013 Nov; 27(11):1969-79. PubMed ID: 24030252
[TBL] [Abstract] [Full Text] [Related]
9. Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Danet-Desnoyers GA; Luongo JL; Bonnet DA; Domchek SM; Vonderheide RH
Exp Hematol; 2005 Nov; 33(11):1275-80. PubMed ID: 16263411
[TBL] [Abstract] [Full Text] [Related]
10. [shp2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
He HY; Zheng J; Li Y; Heng WJ; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
[TBL] [Abstract] [Full Text] [Related]